✦ LIBER ✦

1638 EFFECTS OF 5-ALPHA REDUCTASE INHIBITOR USE IN MONITORED MEN WITH VERY-LOW RISK PROSTATE CANCER

✍ Scribed by Ross, Ashley E.; Zhaoyong, Feng; Pierorazio, Phillip M.; Landis, Patricia; Walsh, Patrick C.; Carter, H. Ballentine; Trock, Bruce J.; Schaeffer, Edward M.

Book ID: 122389404
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 87 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.1747

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of treatment with 5-α reductase i

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer

✍ Ashley E. Ross; Zhaoyong Feng; Phillip M. Pierorazio; Patricia Landis; Patrick C 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Re: Effect of Treatment With 5-α Reducta

Re: Effect of Treatment With 5-α Reductase Inhibitors on Progression in Monitored Men with Favourable-Risk Prostate Cancer

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 128 KB

1780 5-ALPHA REDUCTASE INHIBITORS DIMINI

1780 5-ALPHA REDUCTASE INHIBITORS DIMINISH THE RATE OF PROGRESSION IN MEN WITH LOW RISK PROSTATE CANCER ON ACTIVE SURVEILLANCE

✍ Finelli, Antonio; Trottier, Greg; Lawrentschuk, Nathan; Sowerby, Robert J.; Zlot 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

1092 5-alpha reductase inhibitors dimini

1092 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance

✍ Finelli, A.; Trottier, G.; Lawrentschuk, N.; Sowerby, R.J.; Zlotta, A.R.; Radoms 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 33 KB

844 PHASE II STUDY OF TREATMENT WITH 5-A

844 PHASE II STUDY OF TREATMENT WITH 5-ALPHA REDUCTASE INHIBITORS (5ARIS) IN LOW RISK PROSTATE CANCER

✍ M. Lodde; J. Levesque; L. Lacombe; T. Dujardin; R. Tiguert; Y. Fradet 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 504 KB

POD-4.10: Phase II Study of Treatment wi

POD-4.10: Phase II Study of Treatment with 5-Alpha Reductase Inhibitors (5ARIs) in Low-Risk Prostate Cancer

✍ Y. Fradet; M. Lodde; J. Levesque; F. Harel; L. Lacombe; T. Dujardin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB